ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,387.65
-0.34%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,415.20
-0.26%
Brent Oil
82.155
-0.35%
Bitcoin
70,027.56
-0.15%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. (MM) (PCYC)

  7. (MM) (PCYC) News

(MM) (PCYC)

(MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCYC
DateTimeSourceHeadlineSymbolCompany
15/06/201520:02Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PCYC(MM)
10/06/201517:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PCYC(MM)
05/06/201512:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PCYC(MM)
01/06/201516:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PCYC(MM)
31/05/201514:05PR Newswire (US)Ibrutinib (IMBRUVICA®) Phase Ib/II Data Show Promise in Patients with Chronic Graft-Versus-Host-DiseaseNASDAQ:PCYC(MM)
30/05/201512:31PR Newswire (US)Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Surv...NASDAQ:PCYC(MM)
29/05/201500:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
29/05/201500:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
29/05/201500:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
29/05/201500:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201523:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCYC(MM)
28/05/201514:00PR Newswire (US)Ibrutinib (IMBRUVICA®) in Combination with Anti-PD-L1 Antibody (MEDI4736) Study Commences for Patients with Two Relapsed/Ref...NASDAQ:PCYC(MM)
26/05/201513:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCYC(MM)
26/05/201513:48Edgar (US Regulatory)(25-NSE)NASDAQ:PCYC(MM)
26/05/201513:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PCYC(MM)
26/05/201512:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:32Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:30Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:28Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
26/05/201512:25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PCYC(MM)
 Showing the most relevant articles for your search:NASDAQ:PCYC

Your Recent History

LSE
POLX
Polarean Imaging
LSE
ZED
Zenova
LSE
POS
Plexus
LSE
PHE
Powerhouse Energy
LSE
LLOY
Lloyds Banking
LSE
AAZ
Anglo Asian Mining
LSE
SCLP
Scancell
LSE
GGP
Greatland Gold
LSE
TERN
Tern
LSE
PHNX
Phoenix
LSE
CYAN
Cyanconnode
LSE
AGL
Angle
LSE
RGL
Regional Reit
LSE
VAST
Vast Resources
LSE
SCE
Surface Transforms
LSE
BT.A
Bt
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved